Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update-Reference-Cited by-同舟云学术

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Published:2012-05-17 Issue:3 Volume:6 Page:531-561
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Liaw Yun-Fan,Kao Jia-Horng,Piratvisuth Teerha,Chan Henry Lik Yuen,Chien Rong-Nan,Liu Chun-Jen,Gane Ed,Locarnini Stephen,Lim Seng-Gee,Han Kwang-Hyub,Amarapurkar Deepak,Cooksley Graham,Jafri Wasim,Mohamed Rosmawati,Hou Jin-Lin,Chuang Wan-Long,Lesmana Laurentius A.,Sollano Jose D.,Suh Dong-Jin,Omata Masao

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-012-9365-4.pdf

Reference195 articles.

1. Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008;2:263–283

2. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008;6:1315–1341

3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661–662

4. European Association For The Study Of The Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227–242

5. Liaw YF. Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 2009;51:403–410

Cited by 860 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15

2. Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis;Cancer Medicine;2024-08

3. ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B;Journal of Hepatology;2024-08

4. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

5. Prognostic role of the stromal cell derived factor-1 in patients with hepatitis B virus-related acute-on-chronic liver failure;World Journal of Clinical Cases;2024-07-06